Seven Grand Managers’s Eloxx Pharmaceuticals ELOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,000
Closed -$139K – 223
2026
Q2
$139K Buy
+10,000
New +$128K 0.01% 174

Other funds holding ELOX

Seven Grand Managers's ELOX Position: Q3 2026 in Review

Seven Grand Managers sold out of Eloxx Pharmaceuticals (ELOX) in Q3 2026, closing a stake of 10,000 shares — an estimated $139K sold.

Seven Grand Managers first reported a position in ELOX in Q2 2026 and held it in 1 quarter. The position peaked at $139K in Q2 2026. 20 funds tracked by Wall St. Rank hold ELOX as of Q3 2026.

  • Seven Grand Managers reported no remaining Eloxx Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Seven Grand Managers sold 10,000 Eloxx Pharmaceuticals shares in Q3 2026, an estimated $139K.
  • Seven Grand Managers first reported a position in Eloxx Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • Seven Grand Managers's Eloxx Pharmaceuticals position peaked at $139K in Q2 2026.
  • 20 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals as of Q3 2026.

Based on Seven Grand Managers's 13F filing for Q3 2026, filed 16 Nov 2026.